Published in Blood Weekly, November 24th, 2005
In a recent study from Canada, "virologic and clinical outcomes" in valganciclovir-treated transplant recipients "were compared with those in matched historical control individuals."
"Thirty-two patients (23 with symptomatic disease) received valganciclovir, and 32 patients received intravenous (i.v.) ganciclovir," noted A. Humar and colleagues working at Toronto General Hospital. "The rate of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.